medtronic cardiovascular organic growth in fiscal 2027
Above 9%
medtronic cardiovascular organic growth in fiscal 2027. Best Yes near 65¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 65¢ · Best No: 44¢ · 1 platform
- Kalshi: Yes 65¢ / No 44¢
TRADING OPEN
Above 9%
Volume
$0
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jun 2, 2027
~262 days left
Category
Economics
Yes
65¢
Kalshi
No
44¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Medtronic plc reports Above 9% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jun 2, 2027
Time Left262 days
Status● Active
CategoryEconomics
Yes
65¢
Kalshi
Payout 1.5x
No
44¢
Kalshi
Payout 2.3x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In